{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:21:35Z","timestamp":1791249695897,"version":"4.1.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,11,1]]},"DOI":"10.1093\/humrep\/deh440","type":"journal-article","created":{"date-parts":[[2004,9,10]],"date-time":"2004-09-10T00:23:57Z","timestamp":1094775837000},"page":"2474-2483","source":"Crossref","is-referenced-by-count":113,"title":["Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome"],"prefix":"10.1093","volume":"19","author":[{"given":"Sonya","family":"Kashyap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zev","family":"Rosenwaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,11]]},"reference":[{"key":"key\n\t\t\t\t20171011141052_R1A","doi-asserted-by":"crossref","unstructured":"Adams J, Polson JW, Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J293, 355\u2013359.","DOI":"10.1136\/bmj.293.6543.355"},{"key":"key\n\t\t\t\t20171011141052_R1","doi-asserted-by":"crossref","unstructured":"Berlin JA (1997) Does blinding of readers affect the results of meta-analysis? Lancet350, 185\u2013186.","DOI":"10.1016\/S0140-6736(05)62352-5"},{"key":"key\n\t\t\t\t20171011141052_R2","doi-asserted-by":"crossref","unstructured":"Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D and Laupacis A (1999) Assessing the reliability of randomized trials: reliability of the Jadad scale. Controlled Clin Trials20, 448\u2013452.","DOI":"10.1016\/S0197-2456(99)00026-4"},{"key":"key\n\t\t\t\t20171011141052_R3","doi-asserted-by":"crossref","unstructured":"Dale P, Tanbor T and Vaaler S (1992) Body weight, hypersinulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil Steril58, 487\u2013491.","DOI":"10.1016\/S0015-0282(16)55249-2"},{"key":"key\n\t\t\t\t20171011141052_R4","doi-asserted-by":"crossref","unstructured":"Eijkemans MJC, Imani B, Mulders AGMGJ, Habbema JDF and Fauser BCJM (2003) High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod18, 2357\u20132362.","DOI":"10.1093\/humrep\/deg459"},{"key":"key\n\t\t\t\t20171011141052_R5","unstructured":"El-Biely MM and Habba M (2001) The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndome. Mid East Fertil Soc J6, 43\u201349."},{"key":"key\n\t\t\t\t20171011141052_R6","doi-asserted-by":"crossref","unstructured":"Elkind-Hirsch K, Valdes C and McConnel T (1991) Androgen responses to acutely increased endogenous insulin levels in hyperandrogenic and normal cycling women. Fertil Steril55, 486.","DOI":"10.1016\/S0015-0282(16)54172-7"},{"key":"key\n\t\t\t\t20171011141052_R7","doi-asserted-by":"crossref","unstructured":"ESHRE and ASRM (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome*1. Fertil Steril81, 19\u201325.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"key\n\t\t\t\t20171011141052_R8","doi-asserted-by":"crossref","unstructured":"Farquhar, C., Vandekerckhove, P., Lilford, R (2001) Laparoscopic \u201cdrilling\u201d by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome [update of Cochrane Database Syst Rev. 2000;(2): CD001122; PMID: 10796746]. Cochrane Database of Systematic Reviews CD001122.","DOI":"10.1002\/14651858.CD001122"},{"key":"key\n\t\t\t\t20171011141052_R9","doi-asserted-by":"crossref","unstructured":"Fleming R, Hopkinson ZE, Wallace M, Greer IA and Sattar N (2002) Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab87, 569\u2013574.","DOI":"10.1210\/jcem.87.2.8261"},{"key":"key\n\t\t\t\t20171011141052_R10","unstructured":"Flight, N.R (2002) Insulin-sensitizing drugs for polycystic ovary syndrome (protocol). The Cochrane Library."},{"key":"key\n\t\t\t\t20171011141052_R11","doi-asserted-by":"crossref","unstructured":"Glueck C, Wang P, Fontaine R, Tracy T and Sieve-Smith L (1999) Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with polycystic ovarian syndrome. Metab Clin Exp48, 511\u2013519.","DOI":"10.1016\/S0026-0495(99)90113-0"},{"key":"key\n\t\t\t\t20171011141052_R12","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Wang P, Kobayashi S, Phillips H and Sieve-Smith L (2002) Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril77, 520\u2013525.","DOI":"10.1016\/S0015-0282(01)03202-2"},{"key":"key\n\t\t\t\t20171011141052_R13","doi-asserted-by":"crossref","unstructured":"Gorlitsky G, Kase N and Speroff L (1978) Ovulation and pregnancy rates with clomiphene citrate. Obstet Gynecol51, 265\u2013269.","DOI":"10.1097\/00006250-197803000-00002"},{"key":"key\n\t\t\t\t20171011141052_R14","doi-asserted-by":"crossref","unstructured":"Imani B, Eijkemans MJC, te Velde ER, Habbema JDF and Fauser BCJM (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab83, 2361\u20132365.","DOI":"10.1210\/jc.83.7.2361"},{"key":"key\n\t\t\t\t20171011141052_R15","doi-asserted-by":"crossref","unstructured":"Imani B, Eijkemans MJC, te Velde ER, Habbema JDF and Fauser BCJM (1999) Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab84, 1617\u20131622.","DOI":"10.1210\/jc.84.5.1617"},{"key":"key\n\t\t\t\t20171011141052_R16","doi-asserted-by":"crossref","unstructured":"Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds JM, Gavaghan D and McQuay HJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials17, 1\u201312.","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"key\n\t\t\t\t20171011141052_R17","doi-asserted-by":"crossref","unstructured":"Jadad AR, Moher D and Klassen TP (1998) Guides for reading and interpreting systematic reviews: II. How did the authors find the studies and assess their quality? Arch Pediatr Adolesc Med152, 812\u2013817.","DOI":"10.1001\/archpedi.152.8.812"},{"key":"key\n\t\t\t\t20171011141052_R18","unstructured":"Jakubowicz DJ, Seppala M, Jakubowicz S, Rodriguez-Armas O, Rivas-Santiago A, Koistinen H, Koistinen R and Nestler JE (2001) Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metab86, 1126\u20131133."},{"key":"key\n\t\t\t\t20171011141052_R19","doi-asserted-by":"crossref","unstructured":"Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Roberts KA and Nestler JE (2002) Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab87, 524\u2013529.","DOI":"10.1210\/jcem.87.2.8207"},{"key":"key\n\t\t\t\t20171011141052_R20","doi-asserted-by":"crossref","unstructured":"Juni P, Holenstein F, Sterne J, Bartlett C and Egger M (2002) Direction and impact of language bias in meta-analyses of controlled trials: empirical study [comment]. Int J Epidemiol31, 115\u2013123.","DOI":"10.1093\/ije\/31.1.115"},{"key":"key\n\t\t\t\t20171011141052_R21","doi-asserted-by":"crossref","unstructured":"Kocak M, Caliskan E, Simsir C and Haberal A (2002) Metformin improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril77, 101\u2013106.","DOI":"10.1016\/S0015-0282(01)02941-7"},{"key":"key\n\t\t\t\t20171011141052_R22","doi-asserted-by":"crossref","unstructured":"Kousta E, White DM and Franks S (1997) Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update3, 359.","DOI":"10.1093\/humupd\/3.4.359"},{"key":"key\n\t\t\t\t20171011141052_R23","doi-asserted-by":"crossref","unstructured":"Lord JM, Flight IHK and Norman RJ (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br Med J327, 951\u2013950.","DOI":"10.1136\/bmj.327.7421.951"},{"key":"key\n\t\t\t\t20171011141052_R24","doi-asserted-by":"crossref","unstructured":"Loverro G, Lorusso F, De PagolaNicolardi G, Mei L and Selvaggi L (2002) Clinical and endocrinological effects of 6 months of metformin treatment in young hyperinsulinemic patients affected by polycystic ovarian syndrome. Gynecol Endocrinol16, 217\u2013224.","DOI":"10.1080\/gye.16.3.217.224"},{"key":"key\n\t\t\t\t20171011141052_R25","doi-asserted-by":"crossref","unstructured":"Lunenfeld B, Pariente C, Dor J, Menashe Y, Seppala M, Mortman H and Insler V (1991) Modern aspects of ovulation induction. Ann NY Acad Sci626, 207\u2013216.","DOI":"10.1111\/j.1749-6632.1991.tb37916.x"},{"key":"key\n\t\t\t\t20171011141052_R26","unstructured":"Malkawi HY and Qulban HS (2002) The effect of metformin plus clomiphene citrate on ovulation and pregnancy rates in clomiphene-resistant women with polycystic ovary syndrome. Saudi Med J23, 663\u2013666."},{"key":"key\n\t\t\t\t20171011141052_R27","doi-asserted-by":"crossref","unstructured":"McAuley L, Pham B, Tugwell P and Moher D (2000) Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet356, 1228\u20131231.","DOI":"10.1016\/S0140-6736(00)02786-0"},{"key":"key\n\t\t\t\t20171011141052_R28","doi-asserted-by":"crossref","unstructured":"Messinis IE and Milingos SD (1997) Current and future status of ovulation induction in polycystic ovary syndrome. Hum Reprod Update3, 235\u2013253.","DOI":"10.1093\/humupd\/3.3.235"},{"key":"key\n\t\t\t\t20171011141052_R29","unstructured":"Mitkov M, Simenov S and Pehlivanov B (2002) Effect of metformin treatment of polycystic ovary syndrome. Endocrinologia7, 25\u201329."},{"key":"key\n\t\t\t\t20171011141052_R30","unstructured":"Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E and Muggeo M (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab85, 139\u2013145."},{"key":"key\n\t\t\t\t20171011141052_R31","doi-asserted-by":"crossref","unstructured":"Moher D, Fortin P, Jadad AR, Juni P, Klassen T, Le Lorier J, Liberati A, Linde K and Penna A (1996) Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. [comment]. Lancet347, 363\u2013366.","DOI":"10.1016\/S0140-6736(96)90538-3"},{"key":"key\n\t\t\t\t20171011141052_R32","doi-asserted-by":"crossref","unstructured":"Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D and Stroup DF (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses [comment]. Lancet354, 1896\u20131900.","DOI":"10.1016\/S0140-6736(99)04149-5"},{"key":"key\n\t\t\t\t20171011141052_R33","doi-asserted-by":"crossref","unstructured":"Moher D, Pham B, Klassen TP, Schulz KF, Berlin JA, Jadad AR and Liberati A (2000) What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol53, 964\u2013972.","DOI":"10.1016\/S0895-4356(00)00188-8"},{"key":"key\n\t\t\t\t20171011141052_R34","doi-asserted-by":"crossref","unstructured":"Nagamani M, Dinh T and Kelver M (1986) Hyperinsulinemia in hyperthecosis of the ovaries. Am J Obstet Gynecol154, 384.","DOI":"10.1016\/0002-9378(86)90676-9"},{"key":"key\n\t\t\t\t20171011141052_R35","doi-asserted-by":"crossref","unstructured":"Nestler JE and Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17{alpha} activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med335, 617\u2013623.","DOI":"10.1056\/NEJM199608293350902"},{"key":"key\n\t\t\t\t20171011141052_R36","doi-asserted-by":"crossref","unstructured":"Nestler JE, Jakubowicz DJ, Evans WS and Pasquali R (1998) Effects of metformin on spontaneous and clomiphene induced ovulation in the polycystic ovary syndrome. N Engl J Med338, 1876\u20131880.","DOI":"10.1056\/NEJM199806253382603"},{"key":"key\n\t\t\t\t20171011141052_R37","doi-asserted-by":"crossref","unstructured":"Ng EHY, Wat NMS and Ho PC (2001) Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries:a randomized, double-blind placebo-controlled trial. Hum Reprod16, 1625\u20131631.","DOI":"10.1093\/humrep\/16.8.1625"},{"key":"key\n\t\t\t\t20171011141052_R38","doi-asserted-by":"crossref","unstructured":"Singh I, Bedaiwy MA, Hatwal A, Kumar A and Agarwal A (2001) Increased pregnancy rates with metformin and clomiphene citrate in non-obese patients with polycystic ovary syndrome: prospective randomized study. Fertil Steril76, S94.","DOI":"10.1016\/S0015-0282(01)02280-4"},{"key":"key\n\t\t\t\t20171011141052_R39","doi-asserted-by":"crossref","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. J Am Med Assoc283, 2008\u20132012.","DOI":"10.1001\/jama.283.15.2008"},{"key":"key\n\t\t\t\t20171011141052_R40","doi-asserted-by":"crossref","unstructured":"Sturrock NDC, Lannon B and Fay TN (2001) Metformin does not enhance ovulation induction in clomiphene resistant polycystic ovary syndrome in clinical practice. Br J Pharmacol53, 469\u2013473.","DOI":"10.1046\/j.1365-2125.2002.01575.x"},{"key":"key\n\t\t\t\t20171011141052_R41","doi-asserted-by":"crossref","unstructured":"Vandermolen DT, Ratts VS, Evans WS, Stovall DW, Kauma SW and Nestler JE (2001) Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril75, 310\u2013315.","DOI":"10.1016\/S0015-0282(00)01675-7"},{"key":"key\n\t\t\t\t20171011141052_R42","doi-asserted-by":"crossref","unstructured":"Velazquez E, Mendoza S, Hamer T, Sosa F and Glueck C (1994) Metformin therapy in polycystic ovarian syndrome reduces hyperinsulinema, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metab Clin Exp43, 647\u2013654.","DOI":"10.1016\/0026-0495(94)90209-7"},{"key":"key\n\t\t\t\t20171011141052_R43","doi-asserted-by":"crossref","unstructured":"Yarali H, Yildiz BO, Demirol A, Zeyneloglu HB, Yigit N, Bukulmez O and Koray Z (2002) Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial. Hum Reprod17, 289\u2013294.","DOI":"10.1093\/humrep\/17.2.289"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/19\/11\/2474\/6952065\/deh440.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T13:27:08Z","timestamp":1532784428000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/humrep\/article\/19\/11\/2474\/2356306\/Insulinsensitizing-agents-as-primary-therapy-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,1]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2004,11]]},"published-print":{"date-parts":[[2004,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deh440","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published-other":{"date-parts":[[2004,11]]},"published":{"date-parts":[[2004,11,1]]}}}